EE9800108A - Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid - Google Patents

Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid

Info

Publication number
EE9800108A
EE9800108A EE9800108A EE9800108A EE9800108A EE 9800108 A EE9800108 A EE 9800108A EE 9800108 A EE9800108 A EE 9800108A EE 9800108 A EE9800108 A EE 9800108A EE 9800108 A EE9800108 A EE 9800108A
Authority
EE
Estonia
Prior art keywords
protein
drugs
drugs containing
Prior art date
Application number
EE9800108A
Other languages
English (en)
Inventor
G. Haglid Kenneth
Original Assignee
A+ Science Invest Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest Ab filed Critical A+ Science Invest Ab
Publication of EE9800108A publication Critical patent/EE9800108A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/185Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
EE9800108A 1995-10-17 1996-10-15 Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid EE9800108A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503620A SE505316C2 (sv) 1995-10-17 1995-10-17 Användning av proteinet S-100b för framställning av läkemedel för nervceller
PCT/SE1996/001305 WO1997014427A1 (en) 1995-10-17 1996-10-15 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b

Publications (1)

Publication Number Publication Date
EE9800108A true EE9800108A (et) 1998-10-15

Family

ID=20399846

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800108A EE9800108A (et) 1995-10-17 1996-10-15 Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid

Country Status (11)

Country Link
US (1) US5990080A (et)
EP (1) EP0952844A1 (et)
JP (1) JPH11515003A (et)
AU (1) AU713332B2 (et)
CA (1) CA2235278A1 (et)
CZ (1) CZ116698A3 (et)
EE (1) EE9800108A (et)
NO (1) NO981719L (et)
NZ (1) NZ320721A (et)
SE (1) SE505316C2 (et)
WO (1) WO1997014427A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258776B1 (en) * 1997-08-12 2001-07-10 Novartis Ag Calcium-regulated kinase
US20030108528A1 (en) * 1998-05-19 2003-06-12 Michal Eisenbach-Schwartz Activated t-cells, nervous system-specific antigens and their uses
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
JP2003532618A (ja) * 1998-05-19 2003-11-05 イエダ リサーチ アンド デベロプメント カンパニイ リミテッド 細胞、神経系−特異的抗原およびそれらの用途
DE19915485A1 (de) 1999-04-07 2000-10-19 Hugo A Katus Therapie der Herzinsuffizienz
PT1429800E (pt) * 2001-12-06 2009-04-27 Yeda Res & Dev Vacina e sua utilização para tratamento de esclerose lateral amiotrófica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9164591A (en) * 1990-12-14 1992-07-08 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons

Also Published As

Publication number Publication date
JPH11515003A (ja) 1999-12-21
AU7352396A (en) 1997-05-07
CZ116698A3 (cs) 1998-09-16
WO1997014427A1 (en) 1997-04-24
US5990080A (en) 1999-11-23
CA2235278A1 (en) 1997-04-24
NO981719D0 (no) 1998-04-16
NO981719L (no) 1998-06-16
SE505316C2 (sv) 1997-08-04
NZ320721A (en) 2000-07-28
AU713332B2 (en) 1999-12-02
SE9503620D0 (sv) 1995-10-17
EP0952844A1 (en) 1999-11-03
SE9503620L (sv) 1997-04-18

Similar Documents

Publication Publication Date Title
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
CY2009018I1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα πιογλιταζονη και γλιμεπιριδη για χρηση στην θεραπεια του διαβητη
DE69505657T2 (de) Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DE69815833D1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
EE04566B1 (et) Epotilooni derivaadid ja nende kasutamine meditsiinis
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
NO980878L (no) Mikroporering av menneskehud for medikamentavlevering og overvÕkningsanvendelser
ZA966494B (en) New drugs and their use
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE253835T1 (de) Neutralisierung von sauren nahrungs- und arzneimitteln
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
NO964758D0 (no) Anvendelse av von Willebrand-faktor og farmasöytiske preparater
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
DE59407193D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
EE9800108A (et) Valgu S-100b kasutamine ravimites ja valku S-100b sisaldavad ravimid
ATE281166T1 (de) Tizoxanide und/oder nitazoxanide enthaltende pharmazeutische zubereitungen
EP0776657A3 (de) Kosmetische und/oder pharmazeutische Emulsionen
DK0863878T3 (da) Cycliske nitroner og farmaceutiske præparater indeholdende disse
GB9514816D0 (en) Substances and their medical use